A New Method for Reactivating and Expanding T Cells Specific for Rhizopus oryzae

Molecular Therapy - Methods & Clinical Development - Tập 9 - Trang 305-312 - 2018
Paul Castillo1, Kaylor E. Wright2, Dimitrios P. Kontoyiannis3, Thomas Walsh4,5,6, Shabnum Patel2, Elizabeth Chorvinsky2, Swaroop Bose2, Yasmin Hazrat1, Bilal Omer1, Nathaniel Albert3, Ann M. Leen1, Cliona M. Rooney1, Catherine M. Bollard2, Conrad Russell Y. Cruz2
1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030, USA
2Sheikh Zayed Institute and Center for Cancer and Immunology Research, Children’s National Health System, Washington, DC 20010, USA
3Department of Infectious Diseases, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
4Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA
5Department of Pediatrics, Weill Cornell Medical College, New York, NY 10065, USA
6Department of Microbiology & Immunology, Weill Cornell Medical College, New York, NY 10065, USA

Tài liệu tham khảo

Pizzo, 2011

Leather, 2001, Infections following hematopoietic stem cell transplantation, Infect. Dis. Clin. North Am., 15, 483, 10.1016/S0891-5520(05)70157-4

Thomas, 1999, Bone marrow transplantation: a review, Semin. Hematol., 36, 95

Petrikkos, 2012, Epidemiology and clinical manifestations of mucormycosis, Clin. Infect. Dis., 54, S23, 10.1093/cid/cir866

Binder, 2014, Mucormycosis—from the pathogens to the disease, Clini. Microbiol. Infect., 20, 60, 10.1111/1469-0691.12566

Roden, 2005, Epidemiology and outcome of zygomycosis: a review of 929 reported cases, Clin. Infect. Dis., 41, 634, 10.1086/432579

Bitar, 2009, Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006, Emerg. Infect. Dis., 15, 1395, 10.3201/eid1509.090334

Kontoyiannis, 2005, Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases, J. Infect. Dis., 191, 1350, 10.1086/428780

Ambrosioni, 2010, Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors, Int. J. Infect. Dis., 14, e100, 10.1016/j.ijid.2009.11.024

Park, 2011, Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006, Emerg. Infect. Dis., 17, 1855, 10.3201/eid1710.110087

Neofytos, 2013, Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience, Transpl. Infect. Dis., 15, 233, 10.1111/tid.12060

Lewis, 2012, How does antifungal pharmacology differ for mucormycosis versus aspergillosis?, Clin. Infect. Dis., 54, S67, 10.1093/cid/cir884

Marty, 2016, Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis, Lancet Infect. Dis., 16, 828, 10.1016/S1473-3099(16)00071-2

Pagano, 2006, The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study, Haematologica, 91, 1068

Lanternier, 2012, Mucormycosis in organ and stem cell transplant recipients, Clin. Infect. Dis., 54, 1629, 10.1093/cid/cis195

Fujita, 2008, Adoptive cellular immunotherapy for viral diseases, Bone Marrow Transplant., 41, 193, 10.1038/sj.bmt.1705906

Leen, 2006, Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals, Nat. Med., 12, 1160, 10.1038/nm1475

Papadopoulou, 2014, Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT, Sci. Transl. Med., 6, 242ra83, 10.1126/scitranslmed.3008825

Cortez, 2006, Functional genomics of innate host defense molecules in normal human monocytes in response to Aspergillus fumigatus, Infect. Immun., 74, 2353, 10.1128/IAI.74.4.2353-2365.2006

Roilides, 2012, Host defenses against zygomycetes, Clin. Infect. Dis., 54, S61, 10.1093/cid/cir869

Romani, 2011, Immunity to fungal infections, Nat. Rev. Immunol., 11, 275, 10.1038/nri2939

Potenza, 2011, Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients, Blood, 118, 5416, 10.1182/blood-2011-07-366526

Potenza, 2016, Mucorales-specific T cells in patients with hematologic malignancies, PLoS ONE, 11, e0149108, 10.1371/journal.pone.0149108

Schmidt, 2012, Characterization of the cellular immune responses to Rhizopus oryzae with potential impact on immunotherapeutic strategies in hematopoietic stem cell transplantation, J. Infect. Dis., 206, 135, 10.1093/infdis/jis308

Tramsen, 2013, Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes, Cytotherapy, 15, 344, 10.1016/j.jcyt.2012.11.014

Deo, 2016, Stimulation with lysates of Aspergillus terreus, Candida krusei and Rhizopus oryzae maximizes cross-reactivity of anti-fungal T cells, Cytotherapy, 18, 65, 10.1016/j.jcyt.2015.09.013

Shoham, 2010, Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases, Med. Mycol., 48, 511, 10.3109/13693780903311944

Skiada, 2011, Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007, Clin. Microbiol. Infect., 17, 1859, 10.1111/j.1469-0691.2010.03456.x

Khanna, 2011, Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154, Blood, 118, 1121, 10.1182/blood-2010-12-322610

Hanley, 2015, CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo, Sci. Transl. Med., 7, 285ra63, 10.1126/scitranslmed.aaa2546

Weber, 2013, Generation of multi-leukemia antigen-specific T cells to enhance the graft-versus-leukemia effect after allogeneic stem cell transplant, Leukemia, 27, 1538, 10.1038/leu.2013.66

Leen, 2007, Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells, J. Immunother., 30, 96, 10.1097/01.cji.0000211325.30525.84

Gerdemann, 2012, Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections, Mol. Ther., 20, 1622, 10.1038/mt.2012.130

Kaneko, 2009, IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes, Blood, 113, 1006, 10.1182/blood-2008-05-156059

Huarte, 2009, Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma, Cancer Lett., 285, 80, 10.1016/j.canlet.2009.05.003

Deo, 2015, Adoptive T-cell therapy for fungal infections in haematology patients, Clin. Transl. Immunology, 4, e40, 10.1038/cti.2015.16

Kumaresan, 2014, Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection, Proc. Natl. Acad. Sci. USA, 111, 10660, 10.1073/pnas.1312789111

Cunha, 2010, Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity, Blood, 116, 5394, 10.1182/blood-2010-04-279307

Singh, 2007, Disseminated mucormycosis and orbital ischaemia in combination immunosuppression with a tumour necrosis factor alpha inhibitor, Clin. Experiment. Ophthalmol., 35, 275, 10.1111/j.1442-9071.2007.01458.x

Eddens, 2015, Eosinophils contribute to early clearance of Pneumocystis murina infection, J. Immunol., 195, 185, 10.4049/jimmunol.1403162

Lefèvre, 2015, LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPARγ ligand synthesis, Nat. Commun., 6, 6801, 10.1038/ncomms7801

McLaughlin, 2016, Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes, Cytotherapy, 18, 1515, 10.1016/j.jcyt.2016.08.010

Thông tin
Thông tin xuất bản

Molecular Therapy - Methods & Clinical Development

Tập 9

305-312

Thông tin tác giả